Παρακολούθηση
Robert Hawkins
Robert Hawkins
Cancer Studies, University of Manchester
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα ics.manchester.ac.uk
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma
RJ Motzer, NM Tannir, DF McDermott, O Arén Frontera, B Melichar, ...
New England Journal of Medicine 378 (14), 1277-1290, 2018
39432018
Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial
CN Sternberg, ID Davis, J Mardiak, C Szczylik, J Wagstaff, P Salman, ...
Journal of clinical oncology, 2010
29962010
Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma
BI Rini, ER Plimack, V Stus, R Gafanov, R Hawkins, D Nosov, F Pouliot, ...
New England Journal of Medicine 380 (12), 1116-1127, 2019
27602019
Making antibodies by phage display technology
G Winter, AD Griffiths, RE Hawkins, HR Hoogenboom
Annual review of immunology 12 (1), 433-455, 1994
25651994
Pazopanib versus sunitinib in metastatic renal-cell carcinoma
RJ Motzer, TE Hutson, D Cella, J Reeves, R Hawkins, J Guo, P Nathan, ...
New England Journal of Medicine 369 (8), 722-731, 2013
20592013
Selection of phage antibodies by binding affinity: mimicking affinity maturation
RE Hawkins, SJ Russell, G Winter
Journal of molecular biology 226 (3), 889-896, 1992
10311992
Cancer classification using the Immunoscore: a worldwide task force
J Galon, F Pagès, FM Marincola, HK Angell, M Thurin, A Lugli, I Zlobec, ...
Journal of translational medicine 10, 1-10, 2012
9432012
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3 …
BI Rini, T Powles, MB Atkins, B Escudier, DF McDermott, C Suarez, ...
The Lancet 393 (10189), 2404-2415, 2019
8832019
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
JK Ramage, AHG Davies, J Ardill, N Bax, M Caplin, A Grossman, ...
Gut 54 (suppl 4), iv1-iv16, 2005
7022005
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised …
RJ Motzer, BI Rini, DF McDermott, OA Frontera, HJ Hammers, ...
The Lancet Oncology 20 (10), 1370-1385, 2019
6992019
A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update
CN Sternberg, RE Hawkins, J Wagstaff, P Salman, J Mardiak, CH Barrios, ...
European journal of cancer 49 (6), 1287-1296, 2013
5032013
Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study.
B Escudier, C Porta, P Bono, T Powles, T Eisen, CN Sternberg, ...
4762014
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
AJ Armstrong, S Halabi, T Eisen, S Broderick, WM Stadler, RJ Jones, ...
The Lancet Oncology 17 (3), 378-388, 2016
4062016
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigens
RD Guest, RE Hawkins, N Kirillova, EJ Cheadle, J Arnold, A O'Neill, ...
Journal of immunotherapy 28 (3), 203-211, 2005
3972005
Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial
SR Bramhall, MT Hallissey, J Whiting, J Scholefield, G Tierney, RC Stuart, ...
British journal of cancer 86 (12), 1864-1870, 2002
3632002
Clinical evidence of efficient tumor targetting based on single–chain Fv antibody selected from a combinatorial library
RHJ Begent, MJ Verhaar, KA Chester, JL Casey, AJ Green, MP Napier, ...
Nature Medicine 2 (9), 979-984, 1996
3451996
The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent …
FC Thistlethwaite, DE Gilham, RD Guest, DG Rothwell, M Pillai, DJ Burt, ...
Cancer Immunology, Immunotherapy 66, 1425-1436, 2017
3352017
Retroviral vectors displaying functional antibody fragments
SJ Russell, RE Hawkins, G Winter
Nucleic acids research 21 (5), 1081-1085, 1993
3291993
The optimal antigen response of chimeric antigen receptors harboring the CD3ζ transmembrane domain is dependent upon incorporation of the receptor into the endogenous TCR/CD3 …
JS Bridgeman, RE Hawkins, S Bagley, M Blaylock, M Holland, DE Gilham
The Journal of Immunology 184 (12), 6938-6949, 2010
3102010
Modulation of lymphocyte regulation for cancer therapy: a phase II trial of tremelimumab in advanced gastric and esophageal adenocarcinoma
C Ralph, E Elkord, DJ Burt, JF O'Dwyer, EB Austin, PL Stern, RE Hawkins, ...
Clinical Cancer Research 16 (5), 1662-1672, 2010
2992010
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20